Three of the group’s top cancer drugs were on display – EGFR inhibitor Tagrisso (osimertinib), PD-L1 inhibitor Imfinzi (durvalumab), and Daiichi Sankyo-partnered HER2 antibody-drug conjugate ...

This was a year whose high points included Joan Jonas’s luminous survey, the extravaganza “PST ART,” and the 24-karat beauty of a show “Siena: The Rise of Painting, 1300-1350.” By ...

The EMA's human medicines committee (CHMP) has backed approval of PD-L1 inhibitor Imfinzi (durvalumab) and CTLA4 inhibitor Imjudo (tremelimumab) as a first-line treatment for advanced or ...

Updated results from the OlympiA Phase III trial showed AstraZeneca and Merck & Co., Inc's, known as MSD outside of the US and Canada, LYNPARZA® (olaparib) demonstrated sustained, clinically ...

Non-small-cell lung cancer (NSCLC) treatment has led to improved efficacy and compliance due to individual tailoring of the therapeutic options and the use of strategies based on both clinical ...

There are several types of JIA: Systemic onset JIA. This type affects 1 or more joints. There is often a high fever and a skin rash. It may also cause inflammation of internal organs, including the ...

Eczema is a group of conditions that make your skin inflamed or irritated. The most common type is atopic dermatitis. Conditions That Can Look Like Eczema but Aren’t Your dermatologist or ...

Folliculitis could be caused by a bacterial, fungal, or parasitic infection. The symptoms of folliculitis on the scalp could include: Rash Itching Pimple-like red spots (with a strand of hair in the ...

Giovenzio Genestreti; Francesco Grossi; Carlo Genova; Marco A Burgio; Alberto Bongiovanni; Giampaolo Gavelli; Marco Bartolotti; Monica Di Battista; Giovanna Cavallo; Alba A Brandes S-1 is an oral ...